Drug eDesign Building the next generation of software solutions for drug design
Computer simulations are taking over in design processes. Nevertheless, complex projects will largely benefit from human
intuition and team-work. We aim to combine computer and human power into the next generation of fully interac...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
BES-2012-053600
DESARROLLO E IMPLEMENTACION DE SISTEMAS DE COMPUTACION DE MU...
43K€
Cerrado
DI-14-06634
Mejora del software de diseño de fármacos mediante el uso de...
65K€
Cerrado
UNAH13-4E-2006
Herramientas computacionales para simulaciones biomoleculare...
20K€
Cerrado
ATLAS
Next generation HPC/QC in silico drug discovery platform for...
4M€
Cerrado
SAF2011-30104
CARACTERIZACION DE LAS ESTRUCTURAS DE GPCRS Y SUS INTERACCIO...
97K€
Cerrado
CTQ2017-87974-R
DESARROLLO DE TECNICAS AVANZADAS DE DESCUBRIMIENTO DE FARMAC...
71K€
Cerrado
Información proyecto eDrug
Duración del proyecto: 19 meses
Fecha Inicio: 2014-11-18
Fecha Fin: 2016-06-30
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Computer simulations are taking over in design processes. Nevertheless, complex projects will largely benefit from human
intuition and team-work. We aim to combine computer and human power into the next generation of fully interactive
computational tools for drug design. The goal of eDRUG is prove the potential of this novel computational solution in the
current pipeline of drug development and the prospective interest that it will raise in the pharmaceutical industry.
We aim at merging human knowledge with state of the art affordable computational resources to create an interactive and
(capable of) intuition-guided software solution. The idea seats on three technological pillars: 1) the PELE software allowing
fast biophysical characterization of drug-target interactions, 2) advances in computational hardware providing more
computational performance in reduced space, requiring lower power consumption and acquisition cost, and 3) better
graphical devices allowing a richer and faster human(team) data analysis and software interaction.
The goal matches with increasing and future needs from pharmaceutical companies to improve rational drug design (in
response to cell/virus mutations, personalized medicine, etc.). One worldwide leading pharmaceutical company, and a local biotech SME, will be counseling the developing team and testing the prototypes, to meet a product that fulfills industry expectations.